Evotec and GARDP announce new partnership to discover novel antibiotics

Collaboration explores opportunities to set up antibiotic discovery and development platform and establish a joint pipeline of novel antibiotic assets Discovery efforts will focus on World Health Organisation (“WHO”) priority pathogens

Topics: Corporate, Antibiotic Resistance, Drug Discovery, Gram-negative bacteria, Antibacterial, Evotec, GARDP, WHO Read More

Aptuit's Collaboration with MGH Covered on OneNucleus Spring 2017 Newsletter

Our recent collaboration with Massachusetts General Hospital (MGH) on the identification and validation of novel targets in Gram-negative bacteria is covered in the Spring edition of OneNucleus Newsletter. Read the full article on page 8 with our expert, Antonio Felici.

Topics: Drug design and discovery, Antibiotic Resistance, Gram-negative bacteria, Partner Research Organization, Antibacterial Read More

Most Read

Posts by Topic